Over a 180-day follow-up period, 3,371 individuals (8%) received any AUD treatment, 2,393 (6%) received pharmacotherapy alone, and 215 (0.5%) received both behavioral and pharmacotherapy
You're building clarity so that minor issues get addressed before they escalate, and patterns get identified before they become chronic
Last November, I tried Zepbound, even though it was not covered by insurance
Sometimes followed by a request for a PCSK9 inhibitor instead
Jay Shah, President of the Texas Medical Association (TMA) has provided this guest blog about what the TMA is doing to monitor the issue of pharmacy benefit plan limitations on drug access: To view or add a comment, sign in Definitely a break through for the current situation we are facing with rising Antimocrobial resistance and reported Adverse Drug Reactions, counselling patients with crisp and accurate pointers can change the compliance errors at every means including their perspective related to adherence and importance of completing the prescribed medications